Procept Biorobotics Corp Stock Buy Hold or Sell Recommendation
| PRCT Stock | USD 72.50 0.93 1.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Procept Biorobotics Corp is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Procept Biorobotics Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Procept Biorobotics Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Procept Biorobotics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Procept and provide practical buy, sell, or hold advice based on investors' constraints. Procept Biorobotics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Procept |
Execute Procept Biorobotics Buy or Sell Advice
The Procept recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Procept Biorobotics Corp. Macroaxis does not own or have any residual interests in Procept Biorobotics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Procept Biorobotics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Procept Biorobotics Trading Alerts and Improvement Suggestions
| Procept Biorobotics generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 136.19 M. Net Loss for the year was (105.9 M) with profit before overhead, payroll, taxes, and interest of 114.68 M. | |
| Procept Biorobotics Corp currently holds about 269.81 M in cash with (108 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05. | |
| Over 89.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Spruce Point Capital Management Announces Investment Opinion Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics |
Procept Biorobotics Returns Distribution Density
The distribution of Procept Biorobotics' historical returns is an attempt to chart the uncertainty of Procept Biorobotics' future price movements. The chart of the probability distribution of Procept Biorobotics daily returns describes the distribution of returns around its average expected value. We use Procept Biorobotics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Procept Biorobotics returns is essential to provide solid investment advice for Procept Biorobotics.
| Mean Return | 0.21 | Value At Risk | -5.87 | Potential Upside | 5.18 | Standard Deviation | 5.02 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Procept Biorobotics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Procept Stock Institutional Investors
The Procept Biorobotics' institutional investors refer to entities that pool money to purchase Procept Biorobotics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Franklin Resources Inc | 2024-09-30 | 886 K | Jpmorgan Chase & Co | 2024-09-30 | 812.4 K | T. Rowe Price Associates, Inc. | 2024-09-30 | 777.4 K | Lord, Abbett & Co Llc | 2024-09-30 | 748.6 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 650.8 K | Champlain Investment Partners, Llc | 2024-09-30 | 650.3 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-09-30 | 638.5 K | Bellevue Group Ag | 2024-09-30 | 612.7 K | Bank Of America Corp | 2024-09-30 | 586.5 K | Fmr Inc | 2024-09-30 | 7.3 M | Vanguard Group Inc | 2024-09-30 | 4.8 M |
Procept Biorobotics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (3.1M) | (6.1M) | (15.3M) | (9.8M) | (8.8M) | (9.2M) | |
| Investments | (233K) | (592K) | (2.7M) | (17.4M) | (15.6M) | (14.8M) | |
| Change In Cash | 58.2M | 204.2M | (79.4M) | 34.6M | 31.1M | 38.9M | |
| Free Cash Flow | (48.6M) | (57.9M) | (83.0M) | (133.2M) | (119.9M) | (113.9M) | |
| Depreciation | 2.9M | 3.3M | 2.8M | 3.8M | 4.4M | 3.2M | |
| Other Non Cash Items | (97K) | (345K) | 5.1M | 1.1M | 1.3M | 870.1K | |
| Capital Expenditures | 233K | 592K | 2.7M | 25.2M | 29.0M | 30.4M | |
| Net Income | (53.0M) | (59.9M) | (87.2M) | (105.9M) | (95.3M) | (100.1M) | |
| End Period Cash Flow | 100.9M | 305.1M | 225.7M | 260.3M | 299.3M | 205.6M |
Procept Biorobotics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Procept Biorobotics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Procept Biorobotics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Procept stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | -0.62 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | 0.02 |
Procept Biorobotics Volatility Alert
Procept Biorobotics Corp shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Procept Biorobotics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Procept Biorobotics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Procept Biorobotics Fundamentals Vs Peers
Comparing Procept Biorobotics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Procept Biorobotics' direct or indirect competition across all of the common fundamentals between Procept Biorobotics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Procept Biorobotics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Procept Biorobotics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Procept Biorobotics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Procept Biorobotics to competition |
| Fundamentals | Procept Biorobotics | Peer Average |
| Return On Equity | -0.37 | -0.31 |
| Return On Asset | -0.17 | -0.14 |
| Profit Margin | (0.50) % | (1.27) % |
| Operating Margin | (0.38) % | (5.51) % |
| Current Valuation | 3.76 B | 16.62 B |
| Shares Outstanding | 54.11 M | 571.82 M |
| Shares Owned By Insiders | 4.50 % | 10.09 % |
| Shares Owned By Institutions | 89.05 % | 39.21 % |
| Number Of Shares Shorted | 7.07 M | 4.71 M |
| Price To Book | 16.05 X | 9.51 X |
| Price To Sales | 19.38 X | 11.42 X |
| Revenue | 136.19 M | 9.43 B |
| Gross Profit | 114.68 M | 27.38 B |
| EBITDA | (98.09 M) | 3.9 B |
| Net Income | (105.9 M) | 570.98 M |
| Cash And Equivalents | 269.81 M | 2.7 B |
| Cash Per Share | 6.05 X | 5.01 X |
| Total Debt | 79.2 M | 5.32 B |
| Debt To Equity | 0.23 % | 48.70 % |
| Current Ratio | 16.01 X | 2.16 X |
| Book Value Per Share | 4.63 X | 1.93 K |
| Cash Flow From Operations | (108 M) | 971.22 M |
| Short Ratio | 11.83 X | 4.00 X |
| Earnings Per Share | (1.95) X | 3.12 X |
| Price To Earnings To Growth | (0.47) X | 4.89 X |
| Target Price | 102.75 | |
| Number Of Employees | 626 | 18.84 K |
| Beta | 1.0 | -0.15 |
| Market Capitalization | 3.87 B | 19.03 B |
| Total Asset | 404.72 M | 29.47 B |
| Retained Earnings | (454.57 M) | 9.33 B |
| Working Capital | 304.64 M | 1.48 B |
| Net Asset | 404.72 M |
Note: Acquisition by Dodrill Amy M. of 2526 shares of Procept Biorobotics at 67.29 subject to Rule 16b-3 [view details]
Procept Biorobotics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Procept . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 18712.4 | |||
| Daily Balance Of Power | 0.3577 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 72.63 | |||
| Day Typical Price | 72.59 | |||
| Price Action Indicator | 0.34 | |||
| Period Momentum Indicator | 0.93 |
About Procept Biorobotics Buy or Sell Advice
When is the right time to buy or sell Procept Biorobotics Corp? Buying financial instruments such as Procept Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Procept Biorobotics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.